These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functional and surgical treatments in patients with spinal muscular atrophy (SMA). Boulay C; Peltier E; Jouve JL; Pesenti S Arch Pediatr; 2020 Dec; 27(7S):7S35-7S39. PubMed ID: 33357596 [TBL] [Abstract][Full Text] [Related]
6. [Identification of T274I mutation in the SMN1 gene in a patient with spinal muscular atrophy]. Jedrzejowska M; Wiszniewski W; Ryniewicz B; Hausmanowa-Petrusewicz I Med Wieku Rozwoj; 2002; 6(4):319-27. PubMed ID: 12810984 [TBL] [Abstract][Full Text] [Related]
7. Descriptive epidemiology of spinal muscular atrophy type I in Estonia. Vaidla E; Talvik I; Kulla A; Kahre T; Hamarik M; Napa A; Metsvaht T; Piirsoo A; Talvik T Neuroepidemiology; 2006; 27(3):164-8. PubMed ID: 17035693 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of spinal muscular atrophy (SMA) type 2. Cancès C; Richelme C; Barnerias C; Espil C Arch Pediatr; 2020 Dec; 27(7S):7S18-7S22. PubMed ID: 33357592 [TBL] [Abstract][Full Text] [Related]
10. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity. Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041 [TBL] [Abstract][Full Text] [Related]
11. Spinal muscular atrophy: a time for screening. Prior TW Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691 [TBL] [Abstract][Full Text] [Related]
12. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene. Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346 [TBL] [Abstract][Full Text] [Related]
13. Raising obstetricians' awareness of spinal muscular atrophy: towards early detection and reproductive planning. Parra J; Tizzano EF J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2555-8. PubMed ID: 22712688 [TBL] [Abstract][Full Text] [Related]
16. Implementation of "the consensus statement for the standard of care in spinal muscular atrophy" when applied to infants with severe type 1 SMA in the UK. Roper H; Quinlivan R; Arch Dis Child; 2010 Oct; 95(10):845-9. PubMed ID: 19819869 [TBL] [Abstract][Full Text] [Related]
17. From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1. Al-Zaidy SA; Mendell JR Pediatr Neurol; 2019 Nov; 100():3-11. PubMed ID: 31371124 [TBL] [Abstract][Full Text] [Related]
18. New and developing therapies in spinal muscular atrophy. Kariyawasam D; Carey KA; Jones KJ; Farrar MA Paediatr Respir Rev; 2018 Sep; 28():3-10. PubMed ID: 29703692 [TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular diagnosis of spinal muscular atrophy. Panigrahi I; Kesari A; Phadke SR; Mittal B Neurol India; 2002 Jun; 50(2):117-22. PubMed ID: 12134171 [TBL] [Abstract][Full Text] [Related]